中药调控NLRP3炎症小体防治炎症性肠病"炎-癌"转化作用机制研究进展OA
Research progress on mechanism of traditional Chinese medicine regulating NLRP3 inflammasome in preventing and treating"inflammation-cancer"transformation of inflammatory bowel disease
炎症性肠病(IBD)是一种慢性复发性炎症性疾病,其长期的病理过程与结直肠癌关系密切,涉及"炎-癌"转化这一核心环节.NOD样受体蛋白3(NLRP3)在炎症反应中起重要作用,其异常活化与多种炎症性疾病和肿瘤的发生密切相关.通过系统梳理NLRP3炎症小体在IBD"炎-癌"转化中的核心作用,总结中药通过调控NLRP3炎症小体干预该病病理进程的研究进展,以期为后续相关机制研究和临床干预提供参考.
Inflammatory bowel disease(IBD)is a chronic recurrent inflammatory disorder,whose long-term pathological process is closely associated with colorectal cancer,involving the core mechanism of"inflammation-cancer"transformation.NOD-like receptor protein 3(NLRP3)plays a crucial role in inflammatory responses,and its abnormal activation is closely related to the pathogenesis of various inflammatory diseases and tumors.By systematically reviewing the core role of the NLRP3 inflammasome in the"inflammation-cancer"transformation of IBD,this paper summarizes the research progress on traditional Chinese medicine intervening the pathological process of IBD through regulating the NLRP3 inflammasome.It aims to provide references for subsequent related mechanism research and clinical interventions.
马丽;张丽娜;李生财;万斌;李彦龙
甘肃中医药大学中医临床学院(甘肃 兰州 730000)甘肃省中医院重症医学科(甘肃 兰州 730000)甘肃省中医院脾胃病诊疗中心(甘肃 兰州 730000)山东中医药大学第一临床医学院(山东 济南 250000)甘肃省中医院脾胃病诊疗中心(甘肃 兰州 730000)
炎症性肠病结直肠癌"炎-癌"转化炎症小体中药作用机制
inflammatory bowel diseasecolorectal cancer"inflammation-cancer"transformationinflammasomeChinese materia medicamechanism of action
《上海中医药杂志》 2026 (5)
92-100,9
甘肃省自然科学基金项目(21JR11RA205)甘肃省科技厅青年科技基金计划项目(18JR3RA072)甘肃省第二批陇原青年英才项目(中共甘肃省委人才工作领导小组[2023]11号)敦煌医学与转化教育部重点实验室开放课题(DHYX18-18)2024年度甘肃省中医药科研立项课题(GZKG-2024-44)
评论